Market Research Logo

Medigen Biotechnology Corp (3176) - Financial and Strategic SWOT Analysis Review

Medigen Biotechnology Corp (3176) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses at developing new therapeutics, principally in the area of cancer and liver diseases. The company’s product portfolio includes monoclonal antibodies; vaccines; molecular diagnostics and generic drugs. MBC also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) manufacturing services in various dosage forms including orals, externals, ophthalmic and hormones; nutrition supplements; cosmeceutical products. ’s subsidiaries include Medigen Vaccine Biologics; TBG Biotechnology Corp.; and Winston Medical Supply Co., Ltd. MBC is headquartered in Taipei city, Taiwan.

Medigen Biotechnology Corp Key Recent Developments

Oct 19,2017: MVC co-organized international forum for dengue prevention and vaccine development
Dec 09,2016: MVC Teamed with US CDC to develop VLP Vaccine for Dengue Disease
Nov 23,2016: Medigen Vaccine Biologics’s Inaugurates Taiwan’s First Cell-Based Vaccine Manufacturing Plant
Nov 15,2016: National Health Insurance (NHI) granted two Winston’s product with NHI drug price
Jan 22,2016: MVC was granted National Innovation Award for the application of cell-based production technologies in mock-up vaccine manufacturing

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent Developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Medigen Biotechnology Corp - Key Facts
Medigen Biotechnology Corp - Key Employees
Medigen Biotechnology Corp - Key Employee Biographies
Medigen Biotechnology Corp - Major Products and Services
Medigen Biotechnology Corp - History
Medigen Biotechnology Corp - Company Statement
Medigen Biotechnology Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Medigen Biotechnology Corp - Business Description
Medigen Biotechnology Corp - SWOT Analysis
SWOT Analysis - Overview
Medigen Biotechnology Corp - Strengths
Medigen Biotechnology Corp - Weaknesses
Medigen Biotechnology Corp - Opportunities
Medigen Biotechnology Corp - Threats
Medigen Biotechnology Corp - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Medigen Biotechnology Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 19, 2017: MVC co-organized international forum for dengue prevention and vaccine development
Dec 09, 2016: MVC Teamed with US CDC to develop VLP Vaccine for Dengue Disease
Nov 23, 2016: Medigen Vaccine Biologics’s Inaugurates Taiwan’s First Cell-Based Vaccine Manufacturing Plant
Nov 15, 2016: National Health Insurance (NHI) granted two Winston’s product with NHI drug price
Jan 22, 2016: MVC was granted National Innovation Award for the application of cell-based production technologies in mock-up vaccine manufacturing
Jan 22, 2016: MVC was granted National Innovation Award for the application of cell-based production technologies in mock-up vaccine manufacturing
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Medigen Biotechnology Corp, Key Facts
Medigen Biotechnology Corp, Key Employees
Medigen Biotechnology Corp, Key Employee Biographies
Medigen Biotechnology Corp, Major Products and Services
Medigen Biotechnology Corp, History
Medigen Biotechnology Corp, Other Locations
Medigen Biotechnology Corp, Subsidiaries
Medigen Biotechnology Corp, Key Competitors
Medigen Biotechnology Corp, Ratios based on current share price
Medigen Biotechnology Corp, Annual Ratios
Medigen Biotechnology Corp, Annual Ratios (Cont...1)
Medigen Biotechnology Corp, Annual Ratios (Cont...2)
Medigen Biotechnology Corp, Interim Ratios
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Medigen Biotechnology Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Medigen Biotechnology Corp, Performance Chart (2012 - 2016)
Medigen Biotechnology Corp, Ratio Charts
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Medigen Biotechnology Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report